Regulation of Immune Function by Vitamin D and Its Use in Diseases of Immunity.

Evidence exists for a role for vitamin D and its active metabolites in modulating immune functions. In animal models, vitamin D deficiency is associated with a higher risk for autoimmunity in genetically predisposed subjects and increases in susceptibility to infections. In addition, high-dose vitamin D can improve immune health, prevent autoimmunity, and improve defense against infections. In humans, evidence exists on associations between vitamin D deficiency and impaired immune function, leading to autoimmunity in genetically predisposed people and increased risk for infections; data on therapeutic immune effects of vitamin D supplementation when vitamin D levels are already sufficient are lacking.

[1]  P. Menheere,et al.  Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis , 2014, Multiple sclerosis.

[2]  J. Abe,et al.  Prevention of immunological disorders in MRL/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha,25-dihydroxyvitamin D3. , 1990, Journal of nutritional science and vitaminology.

[3]  C. Mathieu,et al.  Combination of a 1,25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone. , 2003, Bone.

[4]  Sneha S. Joshi,et al.  1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A , 2011, Molecular and Cellular Biology.

[5]  M. Boutron‐Ruault,et al.  Low exposure to sunlight is a risk factor for Crohn’s disease , 2011, Alimentary pharmacology & therapeutics.

[6]  A. Goris,et al.  No evidence for a role of rare CYP27B1 functional variations in multiple sclerosis , 2013, Annals of neurology.

[7]  S. Boonen,et al.  Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. , 2013, The Journal of clinical endocrinology and metabolism.

[8]  C. Mayne,et al.  1,25‐Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis , 2011, European journal of immunology.

[9]  M. Uskoković,et al.  A 1α,25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice , 2002 .

[10]  M. Ban,et al.  No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis , 2013, Annals of Neurology.

[11]  Hong Zhang,et al.  1,25‐dihydroxyvitamin D3 regulates the development of chronic colitis by modulating both T helper (Th)1 and Th17 activation , 2015, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[12]  C. O'Morain,et al.  Vitamin D deficiency in Crohn's disease: prevalence, risk factors and supplement use in an outpatient setting. , 2012, Journal of Crohn's & colitis.

[13]  Pablo Moscato,et al.  Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 , 2009, Nature Genetics.

[14]  R. Steinman Some interfaces of dendritic cell biology , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[15]  F. Aberra,et al.  Vitamin D Deficiency Is Associated with Ulcerative Colitis Disease Activity , 2013, Digestive Diseases and Sciences.

[16]  M. Sodemann,et al.  Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. , 2007, The American journal of clinical nutrition.

[17]  B. Rovin,et al.  Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q , 2012, Lupus.

[18]  A. Achiron,et al.  Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study , 2015, Multiple sclerosis.

[19]  A. Waisman,et al.  The role of IL-17 in CNS diseases , 2015, Acta Neuropathologica.

[20]  C. Mathieu,et al.  1,25-Dihydroxyvitamin D3 and Its Analog TX527 Promote a Stable Regulatory T Cell Phenotype in T Cells from Type 1 Diabetes Patients , 2014, PloS one.

[21]  D. Isenberg,et al.  Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy , 2004, The Journal of experimental medicine.

[22]  C. McCulloch,et al.  Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis , 2012, Annals of neurology.

[23]  K. Badenhoop,et al.  The vitamin D receptor gene FokI polymorphism: Functional impact on the immune system , 2007, European journal of immunology.

[24]  Yun-jie Wang,et al.  The Association Between Genetic Polymorphism rs703842 in CYP27B1 and Multiple Sclerosis , 2016, Medicine.

[25]  L. Adorini,et al.  Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease. , 2010, Immunology letters.

[26]  D. Bruce,et al.  Intrinsic Requirement for the Vitamin D Receptor in the Development of CD8αα-Expressing T Cells , 2011, The Journal of Immunology.

[27]  Y. Jammes,et al.  Vitamin D3 potentiates myelination and recovery after facial nerve injury , 2015, European Archives of Oto-Rhino-Laryngology.

[28]  J. Y. Lee,et al.  Upregulation of interleukin-1β production by 1,25-Dihydroxyvitamin D3 in activated human macrophages , 2011, Molecular Biology Reports.

[29]  L. Newhook,et al.  The geospatial relation between UV solar radiation and type 1 diabetes in Newfoundland , 2010, Acta Diabetologica.

[30]  K. Bennett,et al.  Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study , 2015, United European gastroenterology journal.

[31]  H. Koeffler,et al.  Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. , 2001, Clinical immunology.

[32]  J. Lemire,et al.  1,25-Dihydroxyvitamin D3 Attenuates of Expression of Experimental Murine Lupus of MRL/1 Mice , 1992 .

[33]  Francoise Clavel-Chapelon,et al.  High Residential Sun Exposure Is Associated With a Low Risk of Incident Crohn's Disease in the Prospective E3N Cohort , 2014, Inflammatory bowel diseases.

[34]  C. Mathieu,et al.  1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). , 2000, Diabetes.

[35]  J. Zhong,et al.  Polymorphisms of the vitamin D receptor gene and the risk of inflammatory bowel disease: a meta-analysis. , 2014, Genetics and molecular research : GMR.

[36]  A. Santoni,et al.  Vitamin D3: a transcriptional modulator of the interferon‐γ gene , 1998 .

[37]  Huub F. J. Savelkoul,et al.  1α,25-Dihydroxyvitamin D3 Has a Direct Effect on Naive CD4+ T Cells to Enhance the Development of Th2 Cells1 , 2001, The Journal of Immunology.

[38]  Junliang Pan,et al.  DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 , 2007, Nature Immunology.

[39]  S. Dib,et al.  Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual β-cell function in new-onset type 1 diabetes mellitus. , 2012, Archives of pediatrics & adolescent medicine.

[40]  Ludwig Kappos,et al.  Vitamin D as an early predictor of multiple sclerosis activity and progression. , 2014, JAMA neurology.

[41]  T. Pieber,et al.  Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - A randomized clinical trial. , 2015, Clinical immunology.

[42]  J. Pike,et al.  Regulation of target gene expression by the vitamin D receptor - an update on mechanisms , 2012, Reviews in Endocrine and Metabolic Disorders.

[43]  P. Calabresi,et al.  1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization , 2013, Proceedings of the National Academy of Sciences.

[44]  F. Grodstein,et al.  Exposure to ultraviolet-B and risk of developing rheumatoid arthritis among women in the Nurses’ Health Study , 2013, Annals of the rheumatic diseases.

[45]  David A. Jolliffe,et al.  Vitamin D in the prevention of acute respiratory infection: Systematic review of clinical studies , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[46]  David A. Jolliffe,et al.  Vitamin D deficiency associates with susceptibility to tuberculosis in Pakistan, but polymorphisms in VDR, DBP and CYP2R1 do not , 2016, BMC Pulmonary Medicine.

[47]  T. Pieber,et al.  The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: a randomized controlled trial , 2011, Diabetes/metabolism research and reviews.

[48]  Chao Zhao,et al.  Vitamin D receptor–retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation , 2015, The Journal of cell biology.

[49]  John H. White,et al.  Vitamin D Induces Interleukin-1β Expression: Paracrine Macrophage Epithelial Signaling Controls M. tuberculosis Infection , 2013, PLoS pathogens.

[50]  Andreas Radbruch,et al.  1,25‐dihydroxyvitamin D3 promotes IL‐10 production in human B cells , 2008, European journal of immunology.

[51]  A. Díez-Pérez,et al.  Influence of the BsmI polymorphism of the vitamin D receptor gene on rheumatoid arthritis clinical activity. , 2007, The Journal of rheumatology.

[52]  M. Probst-Kepper,et al.  1α,25-dihydroxyvitamin D3 is a potent suppressor of interferon-γ mediated macrophage activation , 2005 .

[53]  C. Mathieu,et al.  Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3 , 1994, Diabetologia.

[54]  Lauren L. Ritterhouse,et al.  Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus , 2011, Annals of the rheumatic diseases.

[55]  C. Mathieu,et al.  1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. , 2005, Endocrinology.

[56]  S. Mohr,et al.  The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide , 2008, Diabetologia.

[57]  H. DeLuca,et al.  1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. , 1998, The Journal of nutrition.

[58]  L. Deftos,et al.  PTH/PTHrP and Vitamin D Control Antimicrobial Peptide Expression and Susceptibility to Bacterial Skin Infection , 2012, Science Translational Medicine.

[59]  P. Magnus,et al.  Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring , 2000, Diabetologia.

[60]  G. Rook,et al.  Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. , 1986, Immunology.

[61]  L. C. Stene,et al.  Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. , 2003, The American journal of clinical nutrition.

[62]  K. Spach,et al.  IL-10 Signaling Is Essential for 1,25-Dihydroxyvitamin D3-Mediated Inhibition of Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.

[63]  A. Ananthakrishnan,et al.  Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. , 2011, JPEN. Journal of parenteral and enteral nutrition.

[64]  Víctor Potenciano,et al.  The multiple sclerosis-associated regulatory variant rs10877013 affects expression of CYP27B1 and VDR under inflammatory or vitamin D stimuli , 2016, Multiple sclerosis.

[65]  Ning Zhu,et al.  1α,25-Dihydroxyvitamin D3 Induces Neutrophil Apoptosis through the p38 MAPK Signaling Pathway in Chronic Obstructive Pulmonary Disease Patients , 2015, PloS one.

[66]  R. Wilkinson,et al.  Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. , 2005, The Journal of infection.

[67]  M. Clerici,et al.  Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on TH1/TH2 Cytokines in Inflammatory Bowel Disease: An in Vitro Study , 2009, International journal of immunopathology and pharmacology.

[68]  S. Bae,et al.  Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis , 2012, Clinical Rheumatology.

[69]  B. Burstein,et al.  Latitude, sunshine, and human lactase phenotype distributions may contribute to geographic patterns of modern disease: the inflammatory bowel disease model , 2014, Clinical epidemiology.

[70]  L. Kinnunen,et al.  Serum 25-hydroxyvitamin D level during early pregnancy and type 1 diabetes risk in the offspring , 2012, Diabetologia.

[71]  S. Anderson,et al.  VITAMIN D DEFICIENCY AND INSUFFICIENCY IN CHILDREN WITH TUBERCULOSIS , 2008, The Pediatric infectious disease journal.

[72]  P. Menheere,et al.  Association Study on Two Vitamin D Receptor Gene Polymorphisms and Vitamin D Metabolites in Multiple Sclerosis , 2009, Annals of the New York Academy of Sciences.

[73]  A. Barton,et al.  Enrichment of Vitamin D response elements in RA associated loci supports a role for vitamin D in the pathogenesis of RA , 2013, Genes and Immunity.

[74]  H. Nie,et al.  Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis , 2013, Nature Medicine.

[75]  P. Carmeliet,et al.  Vitamin D3 Induces Tolerance in Human Dendritic Cells by Activation of Intracellular Metabolic Pathways. , 2015, Cell reports.

[76]  J. Peters,et al.  1,25‐Dihydroxyvitamin D3 Exerts Opposing Effects to IL‐4 on MHC Class‐II Antigen Expression, Accessory Activity, and Phagocytosis of Human Monocytes , 1993, Scandinavian journal of immunology.

[77]  H. Kalim,et al.  Effects of 1,25(OH)2D3 in immune response regulation of systemic lupus erithematosus (SLE) patient with hypovitamin D. , 2014, International journal of clinical and experimental medicine.

[78]  A. Ananthakrishnan,et al.  Geographical variation and incidence of inflammatory bowel disease among US women , 2012, Gut.

[79]  Songming Huang,et al.  Association between vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus: a meta-analysis , 2014, Rheumatology International.

[80]  J. Gern,et al.  Effects of Vitamin D on Airway Epithelial Cell Morphology and Rhinovirus Replication , 2014, PloS one.

[81]  David F. Richards,et al.  In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines , 2002, The Journal of experimental medicine.

[82]  F. Dall’ara,et al.  Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D , 2015, Lupus.

[83]  Y. Helfrich,et al.  Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. , 2007, The Journal of clinical investigation.

[84]  T. Wynn,et al.  Protective and pathogenic functions of macrophage subsets , 2011, Nature Reviews Immunology.

[85]  Amanda B. Waddell,et al.  The vitamin D receptor turns off chronically activated T cells , 2014, Annals of the New York Academy of Sciences.

[86]  Antonio J. Berlanga-Taylor,et al.  Rare variants in the CYP27B1 gene are associated with multiple sclerosis , 2011, Annals of neurology.

[87]  C. Mathieu,et al.  Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice , 2004, Diabetologia.

[88]  V. Werth,et al.  Characterization of clinical photosensitivity in cutaneous lupus erythematosus. , 2013, Journal of the American Academy of Dermatology.

[89]  G. Amirhakimi,et al.  The rachitic lung. Pulmonary findings in 30 infants and children with malnutritional rickets. , 1977, Clinical pediatrics.

[90]  Weiqian Chen,et al.  Serum Vitamin D Level and Rheumatoid Arthritis Disease Activity: Review and Meta-Analysis , 2016, PloS one.

[91]  S. Lewis,et al.  Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[92]  V. Yong,et al.  Predominance of Th2 polarization by Vitamin D through a STAT6-dependent mechanism , 2011, Journal of Neuroinflammation.

[93]  A. Gholamrezaei,et al.  Vitamin D Deficiency Associated with Disease Activity in Patients with Inflammatory Bowel Diseases , 2015, Digestive Diseases and Sciences.

[94]  F. Cominelli,et al.  Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis , 2015, Inflammatory bowel diseases.

[95]  S. Laban,et al.  Induction of Treg by monocyte‐derived DC modulated by vitamin D3 or dexamethasone: Differential role for PD‐L1 , 2009, European journal of immunology.

[96]  O. Yoshie,et al.  1,25-Dihydroxyvitamin D3 Induces CCR10 Expression in Terminally Differentiating Human B Cells1 , 2008, The Journal of Immunology.

[97]  P. Gibson,et al.  Association of Circulating Vitamin D Concentrations with Intestinal but Not Systemic Inflammation in Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.

[98]  Gavin Giovannoni,et al.  The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[99]  C. Mathieu,et al.  1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism. , 2012, Immunobiology.

[100]  M. Mura,et al.  1,25-Dihydroxyvitamin D3 and IL-2 Combine to Inhibit T Cell Production of Inflammatory Cytokines and Promote Development of Regulatory T Cells Expressing CTLA-4 and FoxP31 , 2009, The Journal of Immunology.

[101]  M. Zali,et al.  Effect of vitamin D3 supplementation on TNF-α serum level and disease activity index in Iranian IBD patients , 2015, Gastroenterology and hepatology from bed to bench.

[102]  B. Abraham,et al.  Vitamin D Deficiency and Corticosteroid Use Are Risk Factors for Low Bone Mineral Density in Inflammatory Bowel Disease Patients , 2014, Digestive Diseases and Sciences.

[103]  E. Bryl,et al.  The role of cytokines in the pathogenesis of rheumatoid arthritis--Practical and potential application of cytokines as biomarkers and targets of personalized therapy. , 2015, Cytokine.

[104]  David A. Jolliffe,et al.  Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data , 2017, British Medical Journal.

[105]  Daniel L. Koller,et al.  Common genetic determinants of vitamin D insufficiency: a genome-wide association study , 2010, The Lancet.

[106]  P. Bhargava,et al.  Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis , 2016, Neurology.

[107]  J. Tuomilehto,et al.  Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999 , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[108]  M. Mahmoudi,et al.  Assessment of 1,25-dihydroxyvitamin D3 effects on Treg cells in a mouse model of systemic lupus erythematosus , 2015, Immunopharmacology and immunotoxicology.

[109]  Xiuwen Tang,et al.  Vitamin D Receptor Gene FokI Polymorphism Contributes to Increasing the Risk of Tuberculosis , 2015, Medicine.

[110]  B. O’Malley,et al.  Nuclear receptor coregulators: modulators of pathology and therapeutic targets , 2012, Nature Reviews Endocrinology.

[111]  Liang Shen,et al.  Assessment of vitamin D levels in type 1 and type 2 diabetes patients: Results from metaanalysis. , 2016, Molecular nutrition & food research.

[112]  E. Huseby,et al.  Pathogenic CD8 T Cells in Multiple Sclerosis and Its Experimental Models , 2012, Front. Immun..

[113]  S. Mellgren,et al.  Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial , 2012, Multiple sclerosis.

[114]  H. Kalim,et al.  Vitamin D prevents endothelial damage induced by increased neutrophil extracellular traps formation in patients with systemic lupus erythematosus. , 2016, Acta medica Indonesiana.

[115]  R. Gallo,et al.  Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. , 2008, The Journal of investigative dermatology.

[116]  M. Behmanesh,et al.  Vitamin D supplementation up-regulates IL-6 and IL-17A gene expression in multiple sclerosis patients. , 2015, International immunopharmacology.

[117]  J. Knight,et al.  Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D , 2009, PLoS genetics.

[118]  L. Adorini,et al.  1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation , 2000, The Journal of Immunology.

[119]  J. Dahlerup,et al.  25-Hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohn’s disease , 2013, Inflammopharmacology.

[120]  C. Mathieu,et al.  The Vitamin D Analog, TX527, Promotes a Human CD4+CD25highCD127low Regulatory T Cell Profile and Induces a Migratory Signature Specific for Homing to Sites of Inflammation , 2011, The Journal of Immunology.

[121]  J. Todd,et al.  Association analyses of the vitamin D receptor gene in 1654 families with type I diabetes , 2009, Genes and Immunity.

[122]  C. Mathieu,et al.  1,25‐Dihydroxyvitamin D3 alters murine dendritic cell behaviour in vitro and in vivo , 2011, Diabetes/metabolism research and reviews.

[123]  A. Ascherio,et al.  Preclinical serum 25-hydroxyvitamin D levels and risk of type 1 diabetes in a cohort of US military personnel. , 2013, American journal of epidemiology.

[124]  J. Adams,et al.  1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. , 1985, Journal of immunology.

[125]  A. Cooke,et al.  Immune cell crosstalk in type 1 diabetes , 2010, Nature Reviews Immunology.

[126]  L. Nguyen,et al.  Alternative Splicing of Vitamin D-24-Hydroxylase , 2005, Journal of Biological Chemistry.

[127]  P. Sørensen,et al.  The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects , 2016, Therapeutic advances in neurological disorders.

[128]  N. Pejnović,et al.  Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. , 1999, Clinical and experimental rheumatology.

[129]  P. Menheere,et al.  Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission , 2011, Journal of Neuroimmunology.

[130]  John H. White,et al.  Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression1 , 2004, The Journal of Immunology.

[131]  M. Campbell,et al.  Vitamin D receptor signaling mechanisms: Integrated actions of a well-defined transcription factor , 2013, Steroids.

[132]  S. Miller,et al.  CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE , 2007, Nature Immunology.

[133]  C. Geisler,et al.  Vitamin D controls T cell antigen receptor signaling and activation of human T cells , 2010, Nature Immunology.

[134]  Wangyang Li,et al.  25-Hydroxyvitamin D concentrations in children with Crohn's disease supplemented with either 2000 or 400 IU daily for 6 months: a randomized controlled study. , 2014, The Journal of pediatrics.

[135]  B. Baslund,et al.  Vitamin D3 metabolism in patients with rheumatic diseases: Low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus , 1995, Clinical Rheumatology.

[136]  L. Adorini,et al.  Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. , 2009, Human immunology.

[137]  D. Bruce,et al.  Failure of T cell homing, reduced CD4/CD8αα intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice , 2008, Proceedings of the National Academy of Sciences.

[138]  R. Wilkinson,et al.  Vitamin D in the treatment of pulmonary tuberculosis , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[139]  K. Raza,et al.  Vitamin D Antagonises the Suppressive Effect of Inflammatory Cytokines on CTLA-4 Expression and Regulatory Function , 2015, PloS one.

[140]  M. Cantorna,et al.  The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells , 2003, Journal of cellular biochemistry.

[141]  G. Pantaleo,et al.  Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects , 2011, Journal of Neuroimmunology.

[142]  L. Freedman,et al.  1,25-Dihydroxyvitamin D3 Inhibits IFN-γ and IL-4 Levels During In Vitro Polarization of Primary Murine CD4+ T Cells1 , 2002, The Journal of Immunology.

[143]  H. Cheroutre,et al.  The thymus chapter in the life of gut-specific intra epithelial lymphocytes. , 2008, Current opinion in immunology.

[144]  F. Nashold,et al.  1,25-Dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis , 2000, Journal of Neuroimmunology.

[145]  F. Borràs,et al.  Comparative study of clinical grade human tolerogenic dendritic cells , 2011, Journal of Translational Medicine.

[146]  J. Piette,et al.  Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation , 2012, Arthritis Research & Therapy.

[147]  T. Chirwa,et al.  Prevalence of common vitamin D receptor gene polymorphisms in HIV-infected and uninfected South Africans. , 2016, International journal of molecular epidemiology and genetics.

[148]  J. Kelsen,et al.  Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double‐blind placebo‐controlled study , 2010, Alimentary pharmacology & therapeutics.

[149]  C. Mathieu,et al.  Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3). , 2002, Diabetes.

[150]  K. Lage,et al.  Differential protein pathways in 1,25-dihydroxyvitamin d(3) and dexamethasone modulated tolerogenic human dendritic cells. , 2012, Journal of proteome research.

[151]  J M Lemire,et al.  1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. , 1991, The Journal of clinical investigation.

[152]  G. Stewart,et al.  Cistromic and genetic evidence that the vitamin D receptor mediates susceptibility to latitude-dependent autoimmune diseases , 2016, Genes and Immunity.

[153]  G. Perigli,et al.  Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. , 2008, Endocrinology.

[154]  L. Joosten,et al.  IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. , 2000, The Journal of clinical investigation.

[155]  S. Manolagas,et al.  1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production. , 1986, Journal of immunology.

[156]  D. Ye,et al.  Seasonal distribution of systemic lupus erythematosus activity and its correlation with climate factors , 2012, Rheumatology International.

[157]  D. Deb,et al.  1,25-Dihydroxyvitamin D Promotes Negative Feedback Regulation of TLR Signaling via Targeting MicroRNA-155–SOCS1 in Macrophages , 2013, The Journal of Immunology.

[158]  A. Cooke,et al.  Type 1 diabetes: translating mechanistic observations into effective clinical outcomes , 2013, Nature Reviews Immunology.

[159]  H. Ohmori,et al.  HUMAN NEUTROPHILS EXPRESS MESSENGER RNA OF VITAMIN D RECEPTOR AND RESPOND TO 1α,25-DIHYDROXYVITAMIN D3 , 2002, Immunopharmacology and immunotoxicology.

[160]  Y. H. Lee,et al.  Vitamin D receptor FokI, BsmI, and TaqI polymorphisms and susceptibility to rheumatoid arthritis , 2015, Zeitschrift für Rheumatologie.

[161]  C. Mathieu,et al.  1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. , 2004, Journal of autoimmunity.

[162]  Z. Farajzadegan,et al.  Efficacy of Vitamin D in patients with active rheumatoid arthritis receiving methotrexate therapy , 2012, Rheumatology International.

[163]  J. Adams,et al.  1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. , 1984, The Journal of clinical investigation.

[164]  Laura Conti,et al.  T‐helper 17 cells expand in multiple sclerosis and are inhibited by interferon‐β , 2009, Annals of neurology.

[165]  M. Cantorna,et al.  1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. , 2000, The Journal of nutrition.

[166]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[167]  B. Henriques-Normark,et al.  Immunomodulatory effects of vitamin D on innate and adaptive immune responses to Streptococcus pneumoniae. , 2013, The Journal of infectious diseases.

[168]  G. Alarcón,et al.  Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. , 2012, Arthritis and rheumatism.

[169]  P. Menheere,et al.  Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis , 2009, PloS one.

[170]  A. Catto-Smith,et al.  Sixty-year Study of Incidence of Childhood Ulcerative Colitis Finds Eleven-fold Increase Beginning in 1990s , 2013, Inflammatory bowel diseases.

[171]  Wei Zhang,et al.  Associations Between Vitamin D Receptor Polymorphisms and Susceptibility to Ulcerative Colitis and Crohn's Disease: A Meta-analysis , 2013, Inflammatory bowel diseases.

[172]  Michael J. Bevan,et al.  CD8+ T Cells: Foot Soldiers of the Immune System , 2011, Immunity.

[173]  Christine L. Taylor,et al.  Dietary Reference Intakes for Calcium and Vitamin D , 2016, Pediatric Clinical Practice Guidelines & Policies.

[174]  K. Lage,et al.  Proteome analysis demonstrates profound alterations in human dendritic cell nature by TX527, an analogue of vitamin D , 2009, Proteomics.

[175]  M. Sodemann,et al.  Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. , 2009, American journal of respiratory and critical care medicine.

[176]  K. Schechtman,et al.  Vitamin D Suppression of Endoplasmic Reticulum Stress Promotes an Antiatherogenic Monocyte/Macrophage Phenotype in Type 2 Diabetic Patients* , 2012, The Journal of Biological Chemistry.

[177]  P. Lipsky,et al.  Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation , 2007, The Journal of Immunology.

[178]  Y. Shoenfeld,et al.  Anti‐Vitamin D, Vitamin D in SLE , 2007, Annals of the New York Academy of Sciences.

[179]  C. Camargo,et al.  Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. , 2009, Archives of internal medicine.

[180]  C. Mathieu,et al.  Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[181]  Qiang Li,et al.  Lower serum 25 (OH) D concentrations in type 1 diabetes: A meta-analysis. , 2015, Diabetes research and clinical practice.

[182]  C. Mathieu,et al.  Vitamin D and cancer , 2013, Cell cycle.

[183]  T. Spector,et al.  Inherited Variation in Vitamin D Genes Is Associated With Predisposition to Autoimmune Disease Type 1 Diabetes , 2011, Diabetes.

[184]  J. Cerhan,et al.  Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. , 2004, Arthritis and rheumatism.

[185]  M. Terreri,et al.  Low serum concentrations of 25-hydroxyvitamin D in children and adolescents with systemic lupus erythematosus , 2014, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[186]  P. Kokhaei,et al.  Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients , 2011, Immunological investigations.

[187]  C. Mathieu,et al.  1,25‐Dihydroxyvitamin D3 Alters the Profile of Bone Marrow‐Derived Dendritic Cells of NOD Mice , 2004, Annals of the New York Academy of Sciences.

[188]  P. Ueda,et al.  Neonatal vitamin D status and risk of multiple sclerosis , 2014, Annals of neurology.

[189]  Christine M. Miller,et al.  The Vitamin D Receptor Regulates Tissue Resident Macrophage Response to Injury. , 2016, Endocrinology.

[190]  D. Hirsch,et al.  Decreased Anti-Inflammatory Responses to Vitamin D in Neonatal Neutrophils , 2011, Mediators of inflammation.

[191]  Jian-Huang Wu,et al.  Association between FokI polymorphism in vitamin D receptor gene and susceptibility to spinal tuberculosis in Chinese Han population. , 2010, Archives of medical research.

[192]  M. Filippi,et al.  A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[193]  Miranda E. Kroehl,et al.  Association between vitamin D metabolism gene polymorphisms and risk of islet autoimmunity and progression to type 1 diabetes: the diabetes autoimmunity study in the young (DAISY). , 2013, The Journal of clinical endocrinology and metabolism.

[194]  C. Mathieu,et al.  Dietary Supplementation With High Doses of Regular Vitamin D3 Safely Reduces Diabetes Incidence in NOD Mice When Given Early and Long Term , 2014, Diabetes.

[195]  J. Goverman Autoimmune T cell responses in the central nervous system , 2009, Nature Reviews Immunology.

[196]  P. Lipsky,et al.  TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. , 2006, Blood.

[197]  P. Gulko,et al.  The Vitamin D Receptor Regulates Rheumatoid Arthritis Synovial Fibroblast Invasion and Morphology , 2012, Molecular medicine.

[198]  F. Cantatore,et al.  Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis , 2014, Clinical and Experimental Medicine.

[199]  M. Radic,et al.  Neutrophil Extracellular Traps: Double-Edged Swords of Innate Immunity , 2012, Journal of Immunology.

[200]  S. Abou-Raya,et al.  The Effect of Vitamin D Supplementation on Inflammatory and Hemostatic Markers and Disease Activity in Patients with Systemic Lupus Erythematosus: A Randomized Placebo-controlled Trial , 2013, The Journal of Rheumatology.

[201]  Yuan Huang,et al.  Inflammatory bowel disease related innate immunity and adaptive immunity. , 2016, American journal of translational research.

[202]  C. Mathieu,et al.  1,25-Dihydroxyvitamin D3 Promotes Tolerogenic Dendritic Cells with Functional Migratory Properties in NOD Mice , 2014, The Journal of Immunology.

[203]  E. Lubberts,et al.  Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. , 2011, Arthritis and rheumatism.

[204]  C. Geisler,et al.  The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+IL‐17+ T Cells in Psoriasis Lesions , 2015, Scandinavian journal of immunology.

[205]  Giuseppe Penna,et al.  Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. , 2005, Blood.

[206]  R. Kerman,et al.  1,25-Dihydroxyvitamin D3 enhances the generation of nonspecific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR. , 1992, Cellular immunology.

[207]  B. Diamond,et al.  The Impact of Vitamin D on Dendritic Cell Function in Patients with Systemic Lupus Erythematosus , 2010, PloS one.

[208]  M. Javan,et al.  Vitamins E and D3 Attenuate Demyelination and Potentiate Remyelination Processes of Hippocampal Formation of Rats Following Local Injection of Ethidium Bromide , 2010, Cellular and Molecular Neurobiology.

[209]  W. James Gauderman,et al.  Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins , 2007, Neurology.

[210]  P. Gregersen,et al.  Randomized, Double‐Blind, Placebo‐Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus , 2015, Arthritis & rheumatology.

[211]  M. Petri,et al.  Assessment of systemic lupus erythematosus. , 2005, Clinical and experimental rheumatology.

[212]  D. Davidson,et al.  Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37 , 2011, PloS one.

[213]  S. Carding,et al.  Inflammatory bowel disease: cause and immunobiology , 2007, The Lancet.

[214]  C. Weaver,et al.  Lineage-specific Effects of 1,25-Dihydroxyvitamin D3 on the Development of Effector CD4 T Cells* , 2010, The Journal of Biological Chemistry.

[215]  E. Karlson,et al.  Association between Residences in U.S. Northern Latitudes and Rheumatoid Arthritis: A Spatial Analysis of the Nurses’ Health Study , 2010, Environmental health perspectives.

[216]  P. Keating,et al.  Effect of vitamin D on T-helper type 9 polarized human memory cells in chronic persistent asthma. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[217]  K. Nilsson,et al.  Functional antagonism between vitamin D3 and retinoic acid in the regulation of CD14 and CD23 expression during monocytic differentiation of U-937 cells. , 1993, Journal of immunology.

[218]  Rongrong Yang,et al.  Polymorphisms in the vitamin D receptor gene and type 1 diabetes mellitus risk: An update by meta-analysis , 2012, Molecular and Cellular Endocrinology.

[219]  P. Lehenkari,et al.  1,25(OH)2D3 and calcipotriol, its hypocalcemic analog, exert a long-lasting anti-inflammatory and anti-proliferative effect in synoviocytes cultured from patients with rheumatoid arthritis and osteoarthritis , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[220]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors , 2007, Annals of neurology.

[221]  H. DeLuca,et al.  Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. , 2003, Archives of biochemistry and biophysics.

[222]  A. Akobeng,et al.  Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis , 2008, Archives of Disease in Childhood.

[223]  A. Hamzaoui,et al.  Contribution of VDR polymorphisms to type 1 diabetes susceptibility: Systematic review of case–control studies and meta-analysis , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[224]  J. M. Burton,et al.  A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis , 2010, Neurology.

[225]  S. Madronich,et al.  Epidemic influenza and vitamin D , 2006, Epidemiology and Infection.

[226]  Glenville Jones PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Expanding Role for Vitamin D in Chronic Kidney Disease: Importance of Blood 25‐OH‐D Levels and Extra‐Renal 1α‐Hydroxylase in the Classical and Nonclassical Actions of 1α,25‐Dihydroxyvitamin D3 , 2007 .

[227]  C. Vasconcelos,et al.  Vitamin D supplementation effects on FoxP3 expression in T cells and FoxP3+/IL-17A ratio and clinical course in systemic lupus erythematosus patients: a study in a Portuguese cohort , 2017, Immunologic research.

[228]  R. Mohamed,et al.  Synergism of CYP2R1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Egyptian children. , 2012, Cellular immunology.

[229]  A. Lerner,et al.  The World Incidence and Prevalence of Autoimmune Diseases is Increasing , 2015 .

[230]  Peter Szolovits,et al.  Normalization of Plasma 25-Hydroxy Vitamin D Is Associated with Reduced Risk of Surgery in Crohn’s Disease , 2013, Inflammatory bowel diseases.

[231]  M. Bugliani,et al.  Discovery of molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse islets of Langerhans. , 2014, Endocrinology.

[232]  A. Ziegler,et al.  Prevalence of vitamin D deficiency in pre-type 1 diabetes and its association with disease progression , 2014, Diabetologia.

[233]  D. Hougaard,et al.  Neonatal vitamin D status and risk of multiple sclerosis , 2017, Neurology.

[234]  S. Gupta,et al.  Calcitriol [1, 25[OH]2 D3] pre- and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells , 2013, European Journal of Nutrition.

[235]  C. Mathieu,et al.  Vitamin D and human health: lessons from vitamin D receptor null mice. , 2008, Endocrine reviews.

[236]  K. Badenhoop,et al.  VDR FokI polymorphism is associated with a reduced T-helper cell population under vitamin D stimulation in type 1 diabetes patients , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[237]  Aristides G. Eliopoulos,et al.  Differential Regulation of Vitamin D Receptor and Its Ligand in Human Monocyte-Derived Dendritic Cells1 , 2003, The Journal of Immunology.

[238]  D. Leung,et al.  Vitamin D in atopic dermatitis, asthma and allergic diseases. , 2010, Immunology and allergy clinics of North America.

[239]  S. Robson,et al.  Vitamin D Levels in Adults with Crohn's Disease Are Responsive to Disease Activity and Treatment , 2014, Inflammatory bowel diseases.

[240]  S. Laban,et al.  Critical Role for TNF in the Induction of Human Antigen-Specific Regulatory T Cells by Tolerogenic Dendritic Cells , 2010, The Journal of Immunology.

[241]  J. Chen,et al.  Vitamin D receptor expression controls proliferation of naïve CD8+ T cells and development of CD8 mediated gastrointestinal inflammation , 2014, BMC Immunology.

[242]  L. Gao,et al.  Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[243]  R. Goswami,et al.  Interaction of Vitamin D Receptor with HLA DRB1*0301 in Type 1 Diabetes Patients from North India , 2009, PloS one.

[244]  T. Ganz,et al.  Macrophages Acquire Neutrophil Granules for Antimicrobial Activity against Intracellular Pathogens1 , 2006, The Journal of Immunology.

[245]  C. Dooms,et al.  1,25-Dihydroxyvitamin D Modulates Antibacterial and Inflammatory Response in Human Cigarette Smoke-Exposed Macrophages , 2016, PloS one.

[246]  N. Shen,et al.  Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. , 2008, Arthritis and rheumatism.

[247]  P. Menheere,et al.  Safety and T Cell Modulating Effects of High Dose Vitamin D3 Supplementation in Multiple Sclerosis , 2010, PloS one.

[248]  Elina Hyppönen,et al.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.

[249]  M. Cantorna,et al.  Mounting Evidence for Vitamin D as an Environmental Factor Affecting Autoimmune Disease Prevalence , 2004, Experimental biology and medicine.

[250]  T. Dwyer,et al.  Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis , 2010, Annals of neurology.

[251]  E. Bonfá,et al.  Vitamin D Supplementation in Adolescents and Young Adults With Juvenile Systemic Lupus Erythematosus for Improvement in Disease Activity and Fatigue Scores: A Randomized, Double‐Blind, Placebo‐Controlled Trial , 2016, Arthritis care & research.

[252]  R. Romero,et al.  The Role of Inflammation and Infection in Preterm Birth , 2007, Seminars in reproductive medicine.

[253]  C. Mathieu,et al.  Immune Regulation of 25‐Hydroxyvitamin‐D3‐1α‐Hydroxylase in Human Monocytes , 2005 .

[254]  K. Spach,et al.  1,25‐dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking , 2007, Journal of neuroscience research.

[255]  M. Owlia,et al.  Role of vitamin D in flare ups of rheumatoid arthritis , 2014, Zeitschrift für Rheumatologie.

[256]  B. Boucher The effects of calcitriol and nicotinamide on residual pancreatic beta-cell funtion in patients with recent-onset Type 1 diabetes (IMDIAB XI). , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[257]  Moses Rodriguez,et al.  CD8+ T cells in multiple sclerosis , 2013, Expert opinion on therapeutic targets.

[258]  M. Cutolo,et al.  Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. , 2006, Clinical and experimental rheumatology.

[259]  P. Ragonese,et al.  Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients , 2016, Neurological Sciences.

[260]  M. Shin,et al.  1,25-Dihyroxyvitamin D3 Promotes FOXP3 Expression via Binding to Vitamin D Response Elements in Its Conserved Noncoding Sequence Region , 2012, The Journal of Immunology.

[261]  M. Worm,et al.  Impaired T cell activation and cytokine production by calcitriol‐primed human B cells , 2014, Clinical and experimental immunology.

[262]  P. Jenum,et al.  Maternal Serum Levels of 25-Hydroxy-Vitamin D During Pregnancy and Risk of Type 1 Diabetes in the Offspring , 2011, Diabetes.

[263]  Y. Taketani,et al.  A Vitamin D Receptor Gene Polymorphism in the Translation Initiation Codon: Effect on Protein Activity and Relation to Bone Mineral Density in Japanese Women , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[264]  R. Bouillon,et al.  Immune regulation of 1α-hydroxylase in murine peritoneal macrophages: Unravelling the IFNγ pathway , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[265]  M. Haussler,et al.  Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms. , 2011, Best practice & research. Clinical endocrinology & metabolism.

[266]  A. Norman,et al.  Minireview: vitamin D receptor: new assignments for an already busy receptor. , 2006, Endocrinology.

[267]  J. V. van Leeuwen,et al.  1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. , 2010, Arthritis and rheumatism.

[268]  J. Adams,et al.  IL-15 Links TLR2/1-Induced Macrophage Differentiation to the Vitamin D-Dependent Antimicrobial Pathway , 2008, The Journal of Immunology.

[269]  S. Shaftman,et al.  Vitamin D deficiency in systemic lupus erythematosus. , 2006, Autoimmunity reviews.

[270]  P. Dhawan,et al.  Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. , 2016, Physiological reviews.

[271]  H. DeLuca,et al.  Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. , 2000, Archives of biochemistry and biophysics.

[272]  John H. White,et al.  Direct and Indirect Induction by 1,25-Dihydroxyvitamin D3 of the NOD2/CARD15-Defensin β2 Innate Immune Pathway Defective in Crohn Disease* , 2009, The Journal of Biological Chemistry.

[273]  C. Hawrylowicz,et al.  The role of 1α,25‐dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+and IL‐10+ CD4+ T cells , 2012, European journal of immunology.

[274]  H. Takayanagi,et al.  Arthritogenic T cells in autoimmune arthritis. , 2015, The international journal of biochemistry & cell biology.

[275]  C. Mathieu,et al.  Vitamin D: modulator of the immune system. , 2010, Current opinion in pharmacology.

[276]  M. Svensson,et al.  Pulmonary tuberculosis patients with a vitamin D deficiency demonstrate low local expression of the antimicrobial peptide LL-37 but enhanced FoxP3+ regulatory T cells and IgG-secreting cells. , 2015, Clinical immunology.

[277]  L. Adorini,et al.  Calcitriol Suppresses Antiretinal Autoimmunity through Inhibitory Effects on the Th17 Effector Response 1 , 2009, The Journal of Immunology.